Price Alert

CTI BioPharma Corp. (CTIC)

NASDAQ: CTIC · Real-Time Price · USD

9.10

0.01 (0.11%)

At close: Jun 23, 2023, 9:58 PM

CTI BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	24.21M	30.42M	32.05M	66.09M	96.9M	65.45M	95.28M	71.88M	33.1M
Short-Term Investments	34.8M	49.52M	49.59M	29.78M	n/a	n/a	n/a	n/a	4.06M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.23M	1.23M	512K	512K	511K	-6.48M	770K	770K	985K
Receivables	22.96M	15.39M	10.59M	8.16M	2.43M	n/a	n/a	n/a	n/a
Inventory	777K	733K	1.15M	702K	102K	n/a	n/a	n/a	n/a
Other Current Assets	3.71M	3.34M	3.56M	2.64M	3.85M	2.93M	3.77M	2.94M	2.18M
Total Current Assets	86.45M	99.4M	96.94M	107.37M	103.28M	68.38M	99.05M	74.82M	39.35M
Property-Plant & Equipment	1.89M	2.08M	2.26M	2.36M	2.83M	3.29M	1.42M	1.91M	2.46M
Goodwill & Intangibles	22.7M	23.23M	23.76M	24.29M	24.82M	7.25M	n/a	n/a	n/a
Total Long-Term Assets	25.82M	26.53M	26.53M	27.16M	28.15M	4.05M	2.19M	2.68M	3.44M
Total Assets	112.27M	125.92M	123.47M	134.53M	131.44M	72.43M	101.23M	77.5M	42.79M
Account Payables	2.02M	2.01M	2.44M	3.1M	2.42M	3.89M	1.78M	1.29M	1.17M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	48.08M	47.94M	n/a	n/a	48.34M	48.54M	48.62M	3.99M	5.53M
Other Current Liabilities	18.12M	31.18M	27.33M	26.69M	48.16M	14.22M	11.94M	10.5M	8.86M
Total Current Liabilities	68.23M	81.13M	29.77M	29.79M	98.93M	66.65M	62.34M	15.79M	15.56M
Long-Term Debt	n/a	n/a	47.8M	49.3M	n/a	2.02M	n/a	n/a	n/a
Other Long-Term Liabilities	69.39M	62.37M	62.73M	60.72M	60.42M	797K	n/a	n/a	577K
Total Long-Term Liabilities	69.39M	62.37M	110.53M	110.02M	60.42M	2.02M	n/a	n/a	577K
Total Liabilities	137.62M	143.5M	140.3M	139.81M	159.35M	68.67M	62.34M	15.79M	16.14M
Total Debt	48.9M	49.96M	49.24M	49.3M	48.34M	50.56M	48.62M	3.99M	5.53M
Common Stock	132K	131K	127K	114K	101K	100K	97K	93K	77K
Retained Earnings	-2.53B	-2.52B	-2.5B	-2.49B	-2.46B	-2.43B	-2.39B	-2.36B	-2.35B
Comprehensive Income	-11K	-35K	-89K	-71K	n/a	n/a	n/a	n/a	-1K
Shareholders Equity	-25.35M	-17.58M	-16.84M	-5.27M	-27.92M	3.77M	38.89M	61.71M	26.65M
Total Investments	34.8M	49.52M	49.59M	29.78M	n/a	n/a	n/a	n/a	4.06M